These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33962533)

  • 21. Treatment of small bowel subocclusive Crohn's disease with infliximab: an open pilot study.
    Louis E; Boverie J; Dewit O; Baert F; De Vos M; D'Haens G;
    Acta Gastroenterol Belg; 2007; 70(1):15-9. PubMed ID: 17619533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.
    Gordon M; Taylor K; Akobeng AK; Thomas AG
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD010233. PubMed ID: 25081347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative Effectiveness of Infliximab Versus Adalimumab in Patients with Biologic-Naïve Crohn's Disease.
    Benmassaoud A; Al-Taweel T; Sasson MS; Moza D; Strohl M; Kopylov U; Paradis-Surprenant L; Almaimani M; Bitton A; Afif W; Lakatos PL; Bessissow T
    Dig Dis Sci; 2018 May; 63(5):1302-1310. PubMed ID: 29243105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease.
    Lichtenstein GR; Olson A; Travers S; Diamond RH; Chen DM; Pritchard ML; Feagan BG; Cohen RD; Salzberg BA; Hanauer SB; Sandborn WJ
    Am J Gastroenterol; 2006 May; 101(5):1030-8. PubMed ID: 16606351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the endoscopic treatment with topical prednisolone administration for intestinal strictures in Crohn's disease.
    Feleshtynskiy Y; Mylianovska A; Pirogovsky V; Dyadyk O
    Pol Przegl Chir; 2021 Sep; 94(1):28-33. PubMed ID: 35195075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can balloon-assisted enteroscopy predict disease outcomes in patients with small-bowel Crohn's disease?
    Na JE; Hong SN; Kim JE; Kim ER; Kim YH; Chang DK
    BMC Gastroenterol; 2023 Sep; 23(1):331. PubMed ID: 37759282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mucosal healing in different intestinal segments in patients receiving infliximab treatment for small bowel Crohn's disease].
    Zhu ZH; Qiu C; Zhang M; Chen Z; Xiang C; Wang XY
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Jan; 37(1):44-48. PubMed ID: 28109097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcomes of patients with Crohn's disease who received infliximab or adalimumab as the first-line biologics.
    Inokuchi T; Takahashi S; Hiraoka S; Toyokawa T; Takagi S; Takemoto K; Miyaike J; Fujimoto T; Higashi R; Morito Y; Nawa T; Suzuki S; Nishimura M; Inoue M; Kato J; Okada H
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1329-1336. PubMed ID: 30724387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for diagnostic delay in Crohn's disease and their impact on long-term complications: how do they differ in a tuberculosis endemic region?
    Banerjee R; Pal P; Girish BG; Reddy DN
    Aliment Pharmacol Ther; 2018 May; 47(10):1367-1374. PubMed ID: 29572889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Long-term Outcomes of Infliximab versus Adalimumab in 1,488 Biologic-Naive Korean Patients with Crohn's Disease.
    Jung YS; Han M; Park S; Cheon JH
    Gut Liver; 2021 Jan; 15(1):92-99. PubMed ID: 32839359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the risk of future gastrointestinal surgery in Crohn's disease with stricture.
    Zeng W; Chen Y; Yin B; Wen X; Xiao J; Luo L; Tang H; Zheng H
    Saudi J Gastroenterol; 2024 Mar; 30(2):108-113. PubMed ID: 38011407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
    Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
    Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn's disease.
    Yang E; Panaccione N; Whitmire N; Dulai PS; Vande Casteele N; Singh S; Boland BS; Collins A; Sandborn WJ; Panaccione R; Battat R
    Aliment Pharmacol Ther; 2020 Jun; 51(11):1031-1038. PubMed ID: 32329532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Managing Stricturing Crohn's Disease: Resect? Strictureplasty? Dilate?
    Lowenfeld L; Michelassi F
    J Laparoendosc Adv Surg Tech A; 2021 Aug; 31(8):881-889. PubMed ID: 34265212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of biologics and other therapies in stricturing Crohn's disease: what have we learnt so far?
    Sorrentino D
    Digestion; 2008; 77(1):38-47. PubMed ID: 18285676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adalimumab versus infliximab in treating post-operative recurrence of Crohn's disease: a national cohort study.
    Preda CM; Fulger LE; Negreanu L; Manuc M; Sandra I; Diculescu MM
    Rev Esp Enferm Dig; 2016 Oct; 108(10):642-647. PubMed ID: 27651132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endoscopic management of stricturing Crohn's disease.
    Gu YB; Zhong J;
    J Dig Dis; 2020 Jun; 21(6):351-354. PubMed ID: 32537911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitubercular Therapy Given to Differentiate Crohn's Disease From Intestinal Tuberculosis Predisposes to Stricture Formation.
    Gupta A; Pratap Mouli V; Mohta S; Kante B; Kalaivani M; Madhu D; Sahu P; Kumar S; Sharma R; Sahni P; Das P; Gupta SD; Makharia G; Kedia S; Ahuja V
    J Crohns Colitis; 2020 Nov; 14(11):1611-1618. PubMed ID: 32369567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined therapy with early initiation of infliximab following drainage of perianal fistulising Crohn's disease: a retrospective cohort study.
    Zhu P; Sun JF; Gu YF; Chen HJ; Xu MM; Li YR; Yang BL
    BMC Gastroenterol; 2022 Jan; 22(1):15. PubMed ID: 35012467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.